TC Group VII S1 sold 19,136,333 MDLN shares at $29.00 (4 days post-IPO); retains 144,375,681 shares
A major shareholder, TC Group VII S1 (10% owner), sold 19,136,333 shares at $29.00 on December 18, 2025, reducing its stake by 11.7% to 144,375,681 shares while retaining a substantial 144.38M-share position. The sale occurred just 4 trading days after Medline's recent listing, with the current price now at $42.18 as of December 22—notably above the transaction price. This filing reflects a partial sale of a specific batch rather than a position exit; the insider's full holdings including derivative securities (per Form 4 Table II) are not yet populated in the database, so the disclosed Table I shares do not represent the complete position. The early post-IPO timing and substantial transaction value ($554,953,657.00) warrant attention from investors monitoring lock-up dynamics and insider positioning in newly listed healthcare companies.